Statistics
Publications
2
Citations
72
H-Index
2
Active since
2021
Affiliations
Rubius Therapeutics (United States)(Current)
Douglas C. McLaughlin is an author at Rubius Therapeutics (United States).
Publications per year
2021–2021
2
2
Engineered red blood cells as an off-the-shelf allogeneic anti-tumor therapeutic
Xuqing Zhang, Mengyao Luo, Shamael R. Dastagir et al. · Nature Communications · 2021 · 53 citations · Full text
1–2 of 2